Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States.

ABSTRACT: Background Despite its high prevalence and clinical significance, clinical measurement of lipoprotein(a) is rare but has not been systematically quantified. We assessed the prevalence of lipoprotein(a) testing overall, in those with various cardiovascular disease (CVD) conditions and in those undergoing cardiac testing across 6 academic medical centers associated with the University of California, in total and by year from 2012 to 2021. Methods and Results In this observational study, data from the University of California Health Data Warehouse on the number of individuals with unique lipoprotein(a) testing, unique CVD diagnoses (using International Classification of Diseases, Tenth Revision [ICD-10], codes), and other unique cardiac testing were collected. The proportion of

SUBMITTER: Bhatia HS 

PROVIDER: S-EPMC10547299 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature